Foshan Radiopharmaceutical

Foshan HTA Radiopharmaceutical Co., Ltd. is a specialized life sciences company focused on the production and distribution of radiopharmaceuticals in Southern China. Established in 1994 and based in Foshan, Guangdong, the company operates as a key regional subsidiary of HTA Co., Ltd., which is part of the China Isotope & Radiation Corporation (CIRC). The company maintains GMP-certified facilities equipped with cyclotrons and automated synthesis modules to produce short-lived isotopes for diagnostic imaging and therapy. Its core product portfolio includes Fluorine-18 labeled Fluorodeoxyglucose (FDG) for PET/CT scans and various Technetium-99m labeled kits for SPECT imaging. Foshan HTA serves as a critical supply hub for hospitals and medical centers across the Guangdong province, supporting advanced diagnostics in oncology, cardiology, and neurology.